GB201309329D0 - Aggregates of superoxide dismutase - Google Patents

Aggregates of superoxide dismutase

Info

Publication number
GB201309329D0
GB201309329D0 GBGB1309329.9A GB201309329A GB201309329D0 GB 201309329 D0 GB201309329 D0 GB 201309329D0 GB 201309329 A GB201309329 A GB 201309329A GB 201309329 D0 GB201309329 D0 GB 201309329D0
Authority
GB
United Kingdom
Prior art keywords
aggregates
superoxide dismutase
dismutase
superoxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB1309329.9A
Other versions
GB2514407A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BR NNSTR M THOMAS
Original Assignee
BR NNSTR M THOMAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BR NNSTR M THOMAS filed Critical BR NNSTR M THOMAS
Priority to GB1309329.9A priority Critical patent/GB2514407A/en
Publication of GB201309329D0 publication Critical patent/GB201309329D0/en
Priority to PCT/IB2014/001008 priority patent/WO2014188269A1/en
Publication of GB2514407A publication Critical patent/GB2514407A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • A61K38/446Superoxide dismutase (1.15)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0089Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/23Immunoglobulins specific features characterized by taxonomic origin from birds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/902Oxidoreductases (1.)
    • G01N2333/90283Oxidoreductases (1.) acting on superoxide radicals as acceptor (1.15)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/10Musculoskeletal or connective tissue disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Peptides Or Proteins (AREA)
GB1309329.9A 2013-05-23 2013-05-23 Aggregates of superoxide dismutase Withdrawn GB2514407A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB1309329.9A GB2514407A (en) 2013-05-23 2013-05-23 Aggregates of superoxide dismutase
PCT/IB2014/001008 WO2014188269A1 (en) 2013-05-23 2014-05-23 Aggregates of superoxide dismutase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1309329.9A GB2514407A (en) 2013-05-23 2013-05-23 Aggregates of superoxide dismutase

Publications (2)

Publication Number Publication Date
GB201309329D0 true GB201309329D0 (en) 2013-07-10
GB2514407A GB2514407A (en) 2014-11-26

Family

ID=48784652

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1309329.9A Withdrawn GB2514407A (en) 2013-05-23 2013-05-23 Aggregates of superoxide dismutase

Country Status (2)

Country Link
GB (1) GB2514407A (en)
WO (1) WO2014188269A1 (en)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001023894A1 (en) * 1999-09-28 2001-04-05 Evotec Oai Ag Quantitative analysis and typification of subcellular particles
US7887803B2 (en) * 2005-12-02 2011-02-15 Amorfix Life Sciences Methods and compositions to treat misfolded-SOD1 mediated diseases
US7794692B2 (en) * 2005-12-02 2010-09-14 Amorfix Life Sciences Ltd. Methods and compositions for detecting amyotrophic lateral sclerosis
DK2514823T3 (en) * 2006-03-03 2018-07-23 Promis Neurosciences Inc Methods and compositions for treating and detecting failed SOD1-mediated diseases
CN101802609A (en) * 2006-07-28 2010-08-11 阿德利夫股份有限公司 peptide probes for diagnostics and therapeutics
US20090171250A1 (en) * 2007-12-27 2009-07-02 Andrey Rybyanets Ultrasound treatment of adipose tissue with fluid injection
CA2819117A1 (en) * 2010-10-26 2012-05-03 University Of Massachusetts Anti-sod1 antibodies and uses thereof
CA2818781C (en) * 2010-12-17 2019-10-08 Neurimmune Holding Ag Human anti-sod1 antibodies

Also Published As

Publication number Publication date
WO2014188269A1 (en) 2014-11-27
GB2514407A (en) 2014-11-26

Similar Documents

Publication Publication Date Title
EP2878520A4 (en) Boundary-section structure of vehicle
SG11201506876XA (en) Modification of polypeptides
HK1217489A1 (en) Flap modulators flap
ZA201406082B (en) Use of ccr3-inhibitors
HK1215241A1 (en) Cu2xsny4 nanoparticles cu2xsny4
HK1218542A1 (en) Flap modulators flap
GB2498523B (en) Safety gate
EP2997482A4 (en) Multi-mode agent
GB201317966D0 (en) Nanoparticles
EP2821073A4 (en) Circadian rhythm-improving agent
GB2513113B (en) Tyres
EP2892529A4 (en) Uses of (-)-perhexiline
DK2831757T3 (en) Vector quantizer
HK1221417A1 (en) Modified hydrogels
GB2499231B (en) Safety gate
GB201309329D0 (en) Aggregates of superoxide dismutase
EP2968557A4 (en) Enhancement of vaccines
LT2994479T (en) Modified expression of prolyl-4-hydroxylase in physcoitrella patens
TWM476074U (en) Motherboard of vehicle
GB201313171D0 (en) Novel use of aggregates
HK1170114A2 (en) One type of range hood
HK1198422A1 (en) Novel uses of colossolactones
GB201213079D0 (en) Novel use of aggregates
TWM476725U (en) Structure of wheelbarrow
GB201303988D0 (en) Mobile safety gate

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)